| |
| |
|
| Insider
Information: |
Lee Tom Y |
| Relationship: |
Chief Executive Office... |
| City: |
San Gabriel |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,001,843 |
|
|
Indirect Shares
|
38,861,282 |
|
|
| Direct
Value |
$446,414 |
|
|
|
Indirect Value
|
$3,468,369 |
|
|
| Total
Shares |
43,863,125 |
|
|
| Total
Value |
$3,914,784 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
17
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
17
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-17.0
|
0.0
|
| Percentage
Gain/Loss : |
 -46.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pure Bioscience |
PURE |
Chief Executive Office... |
2022-12-15 |
5,001,843 |
2022-12-15 |
38,861,282 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • • |
2022-12-15 |
4 |
B |
$0.13 |
$6,550 |
D/D |
50,000 |
5,001,843 |
3.15 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • • |
2022-07-15 |
4 |
A |
$0.15 |
$3,261,250 |
I/I |
21,741,666 |
6,000,000 |
0 |
- |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • • |
2022-03-21 |
4 |
B |
$0.20 |
$36,630 |
D/D |
185,000 |
4,951,843 |
3.23 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • • |
2022-03-17 |
4 |
B |
$0.18 |
$2,372 |
D/D |
13,250 |
4,766,843 |
3.15 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • • |
2022-03-16 |
4 |
B |
$0.18 |
$3,821 |
D/D |
21,227 |
4,753,593 |
3.15 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2021-06-16 |
4 |
B |
$0.43 |
$15,515 |
D/D |
35,998 |
4,732,366 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-12-24 |
4 |
B |
$0.65 |
$553 |
D/D |
851 |
4,696,368 |
2.73 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-12-22 |
4 |
B |
$0.66 |
$29,988 |
D/D |
45,299 |
4,695,517 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-12-21 |
4 |
B |
$0.68 |
$5,344 |
D/D |
7,859 |
4,650,218 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-12-17 |
4 |
B |
$0.65 |
$3,063 |
D/D |
4,712 |
4,642,359 |
2.73 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-12-16 |
4 |
B |
$0.67 |
$13,300 |
D/D |
20,000 |
4,637,647 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,732,222) |
13,401,951 |
0 |
- |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-22 |
4 |
B |
$1.72 |
$22,573 |
D/D |
13,124 |
4,617,647 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-19 |
4 |
B |
$1.85 |
$18,500 |
D/D |
10,000 |
4,604,523 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-18 |
4 |
B |
$1.75 |
$52,497 |
D/D |
30,000 |
4,594,523 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-17 |
4 |
B |
$1.61 |
$43,136 |
D/D |
26,876 |
4,564,523 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-16 |
4 |
B |
$1.62 |
$113,330 |
D/D |
70,000 |
4,537,647 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-15 |
4 |
B |
$1.82 |
$109,200 |
D/D |
60,000 |
4,467,647 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Chief Executive Officer |
• • – |
2020-06-12 |
4 |
B |
$1.91 |
$86,205 |
D/D |
45,157 |
4,407,647 |
2.81 |
% |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2020-03-09 |
4 |
A |
$0.29 |
$650,500 |
I/I |
2,243,103 |
24,134,173 |
0 |
- |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2020-02-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000,000 |
1,000,000 |
0 |
- |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2020-02-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000,000 |
21,891,070 |
0 |
- |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2019-12-19 |
4 |
B |
$0.29 |
$218,161 |
I/I |
754,884 |
22,891,070 |
2.1 |
- |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2019-10-02 |
4/A |
A |
$0.29 |
$290,000 |
I/I |
1,000,000 |
22,136,186 |
0 |
- |
|
| PURE |
Pure Bioscience |
Director |
– • – |
2019-10-02 |
4 |
B |
$0.29 |
$290,000 |
I/I |
1,000,000 |
22,136,186 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
